** AdAlta 1AD.AX soars 33.3% to A$0.012, highest since March 4
** Stock set for biggest intraday gain since March 6, 2024
** Biotechnology firm says SYNthesis BioVentures (SYNBV) to invest up to A$2 mln ($1.3 mln) in seed financing in co's special purpose subsidiary AdCella
** Adds SYNBV has the right to invest another A$5.5 mln in Series A funding round for AdCella on top of its seed financing
** 1AD sheds 25% YTD
($1 = A$1.5780)
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.